--- title: Sionna Therapeutics Sets Terms for Upcoming IPO – Here’s a Quick Peek description: Sionna Therapeutics, Inc. Sets Terms for Upcoming IPO – Here’s a Quick Peek --- [Skip to content](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/sionna-therapeutics-inc.-sets-terms-for-upcoming-ipo-heres-a-quick-peek#main-content) [![IPO_PROPHET_BLUE logo](https://blog.ipoprophet.com/hs-fs/hubfs/IPO_PROPHET_BLUE%20logo.png?width=2973&height=302&name=IPO_PROPHET_BLUE%20logo.png)](https://www.IPOProphet.com) - [Login](https://app.ipoprophet.com/login) Open main navigation Close main navigation - [Login](https://app.ipoprophet.com/login) [Subscribe to our Newsletter](https://share.hsforms.com/1xXldKrGiQBCbNmtOz6j4Jwq3cu4) [Go Back to Home](http://www.ipoprophet.com/) [Go Back to Blog](http://www.ipoprophet.com/blog) Feb 3, 2025 11:35:51 AM # Sionna Therapeutics Sets Terms for Upcoming IPO – Here’s a Quick Peek ![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) Share: [facebook-f icon](http://www.facebook.com/share.php?u=https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/sionna-therapeutics-inc.-sets-terms-for-upcoming-ipo-heres-a-quick-peek) [linkedin-in icon](http://www.linkedin.com/shareArticle?mini=true&url=https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/sionna-therapeutics-inc.-sets-terms-for-upcoming-ipo-heres-a-quick-peek) [Twitter icon](https://twitter.com/intent/tweet?url=https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/sionna-therapeutics-inc.-sets-terms-for-upcoming-ipo-heres-a-quick-peek) [pinterest-p icon](http://pinterest.com/pin/create/link/?url=https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/sionna-therapeutics-inc.-sets-terms-for-upcoming-ipo-heres-a-quick-peek) [envelope icon](mailto:?body=https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/sionna-therapeutics-inc.-sets-terms-for-upcoming-ipo-heres-a-quick-peek) ![Sionna Therapeutics Logo](https://blog.ipoprophet.com/hs-fs/hubfs/Sionna%20Therapeutics%20Logo.png?width=445&height=156&name=Sionna%20Therapeutics%20Logo.png) Sionna Therapeutics, Inc. is set to go public on the Nasdaq Global Market under the ticker symbol "SION." The company is offering 8,823,529 shares of common stock at an estimated price range of $16.00 to $18.00 per share, with a projected post-offer enterprise value of approximately $135.3 million. The lead underwriters for the IPO include Goldman Sachs, TD Securities, Stifel, and Guggenheim Securities. Sionna Therapeutics differentiates itself in the biotechnology sector by focusing on novel treatments for cystic fibrosis (CF), specifically targeting the NBD1 stabilizer and complementary modulator approach to address unmet medical needs. The proceeds from the IPO are expected to be allocated strategically to advance the company’s clinical pipeline. Around $40 million will be dedicated to completing Phase 1 trials and initiating a Phase 2a proof-of-concept trial, while $95 million will support a Phase 2b dose-ranging clinical trial and manufacturing scale-up. Additional funds will be used for research and development, working capital, and general corporate expenses. ![Sionna Therapeutics Pipeline Diagram](https://blog.ipoprophet.com/hs-fs/hubfs/Sionna%20Therapeutics%20Pipeline%20Diagram.png?width=800&height=360&name=Sionna%20Therapeutics%20Pipeline%20Diagram.png) Financially, Sionna remains in a pre-revenue stage, with operating expenses increasing year-over-year as the company invests in its research and development efforts. The company reported losses of $32 million in 2022 and $48 million in 2023, with an estimated $65 million in 2024 as clinical trials progress. Despite these financial challenges, Sionna aims to leverage its innovative CF treatments to establish a strong market presence in the long run. Comparable companies in the biotech sector, such as Revolution Medicines and Apogee Therapeutics, have recently completed IPOs, indicating a positive trend for rare disease-focused biopharmaceutical firms. Post-IPO, the company plans to achieve key clinical milestones, expand late-stage trials, and explore strategic partnerships to strengthen its pipeline. The success of these initiatives will determine Sionna's ability to create long-term shareholder value and establish itself as a leader in cystic fibrosis treatment innovation.   [IPOs](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/ipos), [Sionna Therapeutics](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/sionna-therapeutics) ## Related posts [![](https://blog.ipoprophet.com/hs-fs/hubfs/CBC%20Map.png?height=200&name=CBC%20Map.png)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/central-bancompany-brings-123-years-of-midwestern-banking-heritage-to-wall-street) [IPOs](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/ipos), [Nasdaq](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/nasdaq), [Central Bancompany](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/central-bancompany) ## [Central Bancompany Brings 123 Years of Midwestern Banking Heritage to Wall Street](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/central-bancompany-brings-123-years-of-midwestern-banking-heritage-to-wall-street) ![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) Nov 4, 2025 1:23:04 PM [Read more](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/central-bancompany-brings-123-years-of-midwestern-banking-heritage-to-wall-street) [IPOs](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/ipos), [NYSE](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/nyse), [Hinge Health](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/hinge-health) ## [Hinge Health IPO: Stretching Into the Public Markets](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/hinge-health-ipo-stretching-into-the-public-markets) ![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) May 13, 2025 3:27:29 PM Hinge Health, the tech-driven physical therapy company that helps people get their joints moving,... [Read more](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/hinge-health-ipo-stretching-into-the-public-markets) [![](https://blog.ipoprophet.com/hs-fs/hubfs/National%20Healthcare%20Properties%20Logo.jpg?height=200&name=National%20Healthcare%20Properties%20Logo.jpg)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/national-healthcare-properties-files-558m-ipo-as-senior-housing-growth-strategy-takes-center-stage) [2026](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/2026), [National Healthcare Properties](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/national-healthcare-properties) ## [National Healthcare Properties Files ~$558M IPO as Senior Housing Growth Strategy Takes Center Stage](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/national-healthcare-properties-files-558m-ipo-as-senior-housing-growth-strategy-takes-center-stage) ![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) Apr 20, 2026 1:31:34 PM National Healthcare Properties, Inc. (“NHP”) has filed to go public on the Nasdaq under the ticker... [Read more](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/national-healthcare-properties-files-558m-ipo-as-senior-housing-growth-strategy-takes-center-stage) [linkedin-in icon](https://www.linkedin.com/company/ipo-prophet-software/) [X Twitter icon](https://www.x.com/ipoprophet) --- [![IPO_PROPHET_WHITE-2](https://blog.ipoprophet.com/hs-fs/hubfs/IPO_PROPHET_WHITE-2.png?width=800&height=250&name=IPO_PROPHET_WHITE-2.png "IPO_PROPHET_WHITE-2")](http://www.ipoprophet.com) NONE OF THE CONTENT PUBLISHED ON THE WEBSITE OR MOBILE APP CONSTITUTES A RECOMMENDATION, SOLICITATION, ENDORSEMENT, OR OFFER BY IPO PROPHET™ OR ITS AFFILIATES TO BUY OR SELL ANY SECURITIES, FUTURES, OPTIONS, OR OTHER FINANCIAL INSTRUMENTS, OR PROVIDE ANY INVESTMENT ADVICE OR SERVICE. Copyright © 2025 ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Eric Friedman", "url" : "https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman" }, "dateModified" : "2025-02-03T16:35:51.178Z", "datePublished" : "2025-02-03T16:35:51.000Z", "headline" : "Sionna Therapeutics Sets Terms for Upcoming IPO – Here’s a Quick Peek", "mainEntityOfPage" : { "@id" : "https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/sionna-therapeutics-inc.-sets-terms-for-upcoming-ipo-heres-a-quick-peek", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.ipoprophet.com/hubfs/IPO_PROPHET_BLUE%20logo-1.png" }, "name" : "ipoprophet.com" } } ```